A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern

Cancer

Volumn 117, Issue 6, 2011, Pages 1279-1287

  Carneiro, Ana ^a   Bendahl, Par Ola ^a   Engellau, Jacob ^a   Domanski, Henryk A ^a   Fletcher, Christopher D ^b   Rissler, Pehr ^a   Rydholm, Anders ^a   Nilbert, Mef ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

grade; high risk; infiltrative growth; prognostic model

Indexed keywords

AGE; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LIMB TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; CELL PROLIFERATION; DECISION SUPPORT TECHNIQUES; EXTREMITIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NECROSIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SARCOMA; SOFT TISSUE NEOPLASMS; THORACIC WALL; TUMOR BURDEN;

EID: 79952394852     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25621     Document Type: Article

References (38)

1. Kattan MW, Heller G, Brennan MF., A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med. 2003; 22: 3515-3525. (Pubitemid 37407347)
2. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A., AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2010.
3. Kattan MW, Leung DH, Brennan MF., Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20: 791-796. (Pubitemid 34111387)
4. Eilber FC, Brennan MF, Eilber FR, Dry SM, Singer S, Kattan MW., Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004; 101: 2270-2275. (Pubitemid 39458683)
5. Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005; 103: 402-408. (Pubitemid 40129301)
6. Weiss SW, Goldblum JR., Enzinger and Weiss's soft tissue tumors. 5th ed. Philadelphia, PA: Mosby Elsevier; 2008.
7. Gustafson P, Akerman M, Alvegard TA, et al. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system. Eur J Cancer. 2003; 39: 1568-1576. (Pubitemid 36829197)
8. Gustafson P., Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 1994; 259: 1-31. (Pubitemid 24227011)
9. Engellau J, Bendahl PO, Persson A, et al. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol. 2005; 36: 994-1002. (Pubitemid 41253386)
10. Engellau J, Samuelsson V, Anderson H, et al. Identification of low-risk tumours in histological high-grade soft tissue sarcomas. Eur J Cancer. 2007; 43: 1927-1934. (Pubitemid 47284864)
11. Fletcher C, Unni K, Mertens F., Pathology and genetics of tumors of soft tissue and bone. Lyon, France: IARC; 2002.
12. Sobin L, Gospodarowcz MK, Wittekind C., TNM classification of malignant tumors. 7th ed. Hoboken, NJ: Wiley-Blackwell; 2009.
13. Altman D., Practical statistics for medical research. Vol 1. London, UK: Chapman & Hall; 1991.
14. Schoenfeld D., Partial residuals for the proportional hazards regression model Biometrika. 1982; 69: 3.
15. Royston P, Sauerbrei W., Multivariate model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. West Sussex, UK: John Wiley & Sons; 2008.
16. Altman DG, Bland JM., Diagnostic tests 2: predictive values. BMJ. 1994; 309: 102. (Pubitemid 24216428)
17. Dujardin B, Van den Ende J, Van Gompel A, Unger JP, Van der Stuyft P., Likelihood ratios: a real improvement for clinical decision making? Eur J Epidemiol. 1994; 10: 29-36. (Pubitemid 24245461)
18. Deeks JJ, Altman DG., Diagnostic tests 4: likelihood ratios. BMJ. 2004; 329: 168-169.
19. Grimes DA, Schulz KF., Refining clinical diagnosis with likelihood ratios. Lancet. 2005; 365: 1500-1505. (Pubitemid 40591696)
20. Harrell FE Jr, Lee KL, Mark DB., Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15: 361-387. (Pubitemid 26072233)
21. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001; 91: 1914-1926. (Pubitemid 32424119)
22. Coindre JM, Blanc-Vincent MP, Collin F, et al. Standards, options and recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients [in French]. Bull Cancer. 2001; 88: 765-773. (Pubitemid 32896845)
23. van Unnik JA, Coindre JM, Contesso C, et al. Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer. 1993; 29A: 2089-2093. (Pubitemid 23348121)
24. Rydholm A, Gustafson P., Should tumor depth be included in prognostication of soft tissue sarcoma? BMC Cancer. 2003; 3: 17.
25. Zettersten E, Shaikh L, Ramirez R, Kashani-Sabet M., Prognostic factors in primary cutaneous melanoma. Surg Clin North Am. 2003; 83: 61-75. (Pubitemid 36384360)
26. Ghossein R., Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. Arch Pathol Lab Med. 2009; 133: 683-691.
27. Prat J., Prognostic parameters of endometrial carcinoma. Hum Pathol. 2004; 35: 649-662. (Pubitemid 38881074)
28. Heidenreich A, Srivastava S, Moul JW, Hofmann R., Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors. Eur Urol. 2000; 37: 121-135. (Pubitemid 30103062)
29. Mandard AM, Petiot JF, Marnay J, et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer. 1989; 63: 1437-1451. (Pubitemid 19084571)
30. Costa J, Wesley RA, Glatstein E, Rosenberg SA., The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984; 53: 530-541. (Pubitemid 14182732)
31. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984; 33: 37-42. (Pubitemid 14223231)
32. Tomita Y, Aozasa K, Myoui A, et al. Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count. Int J Cancer. 1993; 54: 194-199. (Pubitemid 23154881)
33. Dinges S, Budach V, Budach W, Feldmann HJ, Stuschke M, Sack H., Local recurrences of soft tissue sarcomas in adults: a retrospective analysis of prognostic factors in 102 cases after surgery and radiation therapy. Eur J Cancer. 1994; 30A: 1636-1642. (Pubitemid 24355480)
34. Lack EE, Steinberg SM, White DE, et al. Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol. 1989; 41: 263-273. (Pubitemid 19200461)
35. Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997; 15: 350-362. (Pubitemid 27020593)
36. Brown FM, Fletcher CD., Problems in grading soft tissue sarcomas. Am J Clin Pathol. Nov 2000; 114 (suppl): S82-S89.
37. Blay JY, Le Cesne A., Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven. Oncologist. 2009; 14: 1013-1020.
38. Schuetze SM, Patel S., Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Oncologist. 2009; 14: 1003-1012.